Atlas Trials

Prolonged Adjuvant Temozolomide vs "Stop & Go" in Glioblastoma Patients

Clinical trial NCT00643825 · UNKNOWN

Trial details

NCT number
NCT00643825
Sponsor
Cliniques universitaires Saint-Luc- Université Catholique de Louvain
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Glioblastoma
Start date
2008-01-01
Primary completion
2011-01-01
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.